معرفی
Professor Adam McCluskey is a leading academic at the University of Newcastle's School of Environmental and Life Sciences (Department of Chemistry). He heads the chemistry component of the Centre for Kinomics, a world-first facility focused on kinase research and drug design for epilepsy, cancer, and neuropathic pain. His work bridges medicinal chemistry and chemical biology, with a focus on endocytosis inhibitors and kinase-targeted therapies.
He holds a PhD and BSc (Hons) from the University of Strathclyde. His research includes developing novel drug candidates, such as dynamin modulators and endocytosis inhibitors, and collaborating with institutions like the Children's Medical Research Institute and HMRI. Key achievements include establishing the dynamin modulators platform and pioneering flow chemistry laboratories in Australia.
Research interests span drug design, protein kinases, and therapeutic development. His work on the Centre for Kinomics leverages Kinobead technology to rapidly profile drug-kinase interactions, revolutionizing drug discovery.
Major grants include a $3.1M Australian Cancer Research Foundation grant and a $1M Ramaciotti Foundation award. Awards include the 2005 Vice-Chancellor’s Teaching Excellence Award. His lab collaborates internationally and focuses on translating chemical probes into clinical applications.
